Strategic Partnerships Leverage URSAPHARM's HYLO eye care brand and existing distribution channels in Spain to explore co-branded promotions, exclusive SKUs, or bundled ophthalmology offerings with local distributors and clinics.

Ophthalmology Focus Target ophthalmology networks, surgical centers, and optometry groups with advanced eye care solutions, highlighting URSAPHARM's heritage in ophthalmology and potential for new device integrations or companion meds.

International Reach Capitalize on URSAPHARM's international operations by proposing cross-border product launches or regional clinical studies that align with European and global eye health demand, supported by their existing regulatory footprint.

Innovation Synergy Propose joint R&D or repurposing collaborations (as seen with azelastine hydrochloride) to address emergent therapies or pandemic-related niches, expanding URSAPHARM's portfolio beyond standalone ophthalmic products.

Brand Expansion Explore sponsorships, co-marketing with sports or esports affiliations, and digital health engagement to raise HYLO visibility among both clinicians and end-users, driving upsell opportunities for eye care solutions.